申请人:The United States of America as represented by the Department of Health,
公开号:US04014885A1
公开(公告)日:1977-03-29
5,6-Dihydro-6-alkoxynitidine compounds of the formula ##STR1## wherein R.sub.1 and R.sub. 2 are selected independently from the group consisting of C.sub.1 -C.sub.6 alkyl groups, H and benzyl or R.sub.1 and R.sub.2 taken together are methylene and R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are selected independently from the group consisting of C.sub.1 -C.sub.6 alkyl groups, H and benzyl are anti-leukemic agents.
公式为##STR1##的5,6-二氢-6-烷氧基硝基啶化合物,其中R.sub.1和R.sub.2独立地选自C.sub.1-C.sub.6烷基、氢和苄基的群体,或者R.sub.1和R.sub.2一起是亚甲基,而R.sub.3、R.sub.4、R.sub.5和R.sub.6独立地选自C.sub.1-C.sub.6烷基、氢和苄基的群体,是抗白血病剂。